Assessment of Sleep Quality in Cannabinoid Therapy

NCT05237037 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 34

Last updated 2023-02-08

No results posted yet for this study

Summary

The current study aims to assess the impact of starting cannabinoid therapy on sleep quality for individuals with sleep disturbance.

Conditions

  • Poor Sleep Quality

Sponsors & Collaborators

  • Ekosi Health Centre

    collaborator UNKNOWN
  • Cerebra Medical

    lead INDUSTRY

Eligibility

Min Age
40 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-08-22
Primary Completion
2023-08-31
Completion
2023-08-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05237037 on ClinicalTrials.gov